mepivacaine hydrochloride en es it fr

mepivacaine hydrochloride Brand names, mepivacaine hydrochloride Analogs

mepivacaine hydrochloride Brand Names Mixture

  • No information avaliable

mepivacaine hydrochloride Chemical_Formula

C4H11N5

mepivacaine hydrochloride RX_link

http://www.rxlist.com/cgi/generic4/glumetza.htm

mepivacaine hydrochloride fda sheet

mepivacaine_hydrochloride FDA

mepivacaine hydrochloride msds (material safety sheet)

mepivacaine_hydrochloride MSDS

mepivacaine hydrochloride Synthesis Reference

No information avaliable

mepivacaine hydrochloride Molecular Weight

129.164 g/mol

mepivacaine hydrochloride Melting Point

223-226 oC

mepivacaine hydrochloride H2O Solubility

Freely soluble as HCl salt

mepivacaine hydrochloride State

Solid

mepivacaine hydrochloride LogP

-0.267

mepivacaine hydrochloride Dosage Forms

Extended release tablet (500 mg or 1000 mg)

mepivacaine hydrochloride Indication

For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.

mepivacaine hydrochloride Pharmacology

Metformin is an antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may actually decrease.

mepivacaine hydrochloride Absorption

Absorbed over 6 hours, bioavailability is 50 to 60% under fasting conditions. Food delays absorption.

mepivacaine hydrochloride side effects and Toxicity

Acute oral toxicity (LD50): 350 mg/kg [Rabbit]. It would be expected that adverse reactions of a more intense character including epigastric discomfort, nausea, and vomiting followed by diarrhea, drowsiness, weakness, dizziness, malaise and headache might be seen.

mepivacaine hydrochloride Patient Information

mepivacaine hydrochloride Organisms Affected

Humans and other mammals